Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
Enfusion Inc (NYSE: ENFN) closed the day trading at $10.69 up 1.04% from the previous closing price of $10.58. In other words, the price has increased by $1.04 from its previous closing price. On the day, 0.56 million shares were traded. ENFN stock price reached its highest trading level at $11.16 during the session, while it also had its lowest trading level at $10.47.
Ratios:
For a better understanding of ENFN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 28.46 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 69.00. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.30 whereas as Long-Term Debt/Eq ratio is at 0.22.
On February 28, 2024, Goldman Downgraded its rating to Sell which previously was Neutral and also lowered its target price recommendation from $9 to $8.
JP Morgan Downgraded its Neutral to Underweight on January 30, 2024, whereas the target price for the stock was revised from $11 to $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 20 ’24 when Herring Bradley sold 24,443 shares for $10.61 per share. The transaction valued at 259,340 led to the insider holds 270,503 shares of the business.
Herring Bradley bought 24,443 shares of ENFN for $259,416 on Dec 20 ’24. On Dec 03 ’24, another insider, Pawar Neal, who serves as the Chief Operating Officer of the company, sold 26,246 shares for $10.09 each. As a result, the insider received 264,822 and left with 1,117,298 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENFN now has a Market Capitalization of 1008837696 and an Enterprise Value of 1002258112. As of this moment, Enfusion’s Price-to-Earnings (P/E) ratio for their current fiscal year is 408.02, and their Forward P/E ratio for the next fiscal year is 36.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.04 while its Price-to-Book (P/B) ratio in mrq is 14.26. Its current Enterprise Value per Revenue stands at 5.136 whereas that against EBITDA is 54.097.
Stock Price History:
Over the past 52 weeks, ENFN has reached a high of $11.38, while it has fallen to a 52-week low of $7.52. The 50-Day Moving Average of the stock is 9.26%, while the 200-Day Moving Average is calculated to be 17.02%.
Shares Statistics:
Over the past 3-months, ENFN traded about 414.86K shares per day on average, while over the past 10 days, ENFN traded about 564660 shares per day. A total of 93.26M shares are outstanding, with a floating share count of 49.54M. Insiders hold about 47.50% of the company’s shares, while institutions hold 59.45% stake in the company. Shares short for ENFN as of 1732838400 were 820410 with a Short Ratio of 1.96, compared to 1730332800 on 1178460. Therefore, it implies a Short% of Shares Outstanding of 820410 and a Short% of Float of 1.7999999999999998.
